Oncolytics Biotech® Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics

Oncolytics Biotech® Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics

SAN DIEGO, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced the appointment of John McAdory as Executive Vice President of Strategy and Operations and Yujun…

Oncolytics names John McAdory EVP strategy and operations; Yujun Wu VP biostatistics - BioTuesdays

Oncolytics Biotech (NASDAQ: ONCY) has announced the appointments of John McAdory as executive vice president (EVP), strategy and operations, and Yujun Wu as vice president (VP), head of biostatistics. According to Oncolytics, these appointments are expected to enhance the company’s operational, clinical, and regulatory capabilities as it advances registration-directed development programs in pancreatic, colorectal, and anal cancers. Mr. McAdory …